How many institutions held CYCC - Cyclacel Pharmaceuticals, Inc. - Common Stock, $0.001 par value in Q1 2025?

20 institutional investors reported CYCC - Cyclacel Pharmaceuticals, Inc. - Common Stock, $0.001 par value for Q1 2025. Use the holders table for investor-level position and value details.

Cyclacel Pharmaceuticals, Inc. - Common Stock, $0.001 par value (CYCC)

Q: What does CUSIP 23254L801 represent in this 13F holders report?

CUSIP 23254L801 is the security identifier for CYCC - Cyclacel Pharmaceuticals, Inc. - Common Stock, $0.001 par value used to aggregate holder disclosures.

CUSIP: 23254L801

Q1 2025 13F Holders as of 31 Mar 2025

Security type / class: Equity / Common Stock, $0.001 par value
Total 13F shares: 1,626,479
Total 13F value: $454,098
Share change: +922,437
SEC-reported price per share: $0.28
Number of holders: 20
Value change: +$256,529
Number of buys: 10
Number of sells: 2
Shares outstanding: 1,584,707

Security key

23254L801

Report period

Q1 2025

Institutions

Top holders

CYCC full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2025 Bio Green Med Solution, Inc. SEC filings Bio Green Med Solution, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 23254L801

Newer quarter: Q3 2025

Recent filing periods:

Q3 2025

Ownership snapshot

Top reported holders of CYCC - Cyclacel Pharmaceuticals, Inc. - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Datuk Dr. Doris Wong Sing Ee

Disclosed value leader

Datuk Dr. Doris Wong Sing Ee

Comparable rows

2/15

Latest evidence

31 Mar 2025

13D/G 13F 3/4/5 Lead comparable stake: 70% 13 rows are not safely comparable across share classes. 13D/G row: Datuk Dr. Doris Wong Sing Ee Showing 1-6 of 15 holder rows.

Quick read

Datuk Dr. Doris Wong Sing Ee leads the comparable SEC ownership view at 70%.

2 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Datuk Dr. Doris Wong Sing Ee's linked filing trail.

Comparable ownership Top 2

Datuk Dr. Doris Wong Sing Ee 70%

ARMISTICE CAPITAL, LLC 9.2%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Datuk Dr. Doris Wong Sing Ee	13D/G Doris Wong Sing Ee 13D/G	70% Reported 13D/G · 26 Feb 2025	$58,388,646 194,628,820 shares	$0	26 Feb 2025
ARMISTICE CAPITAL, LLC	13D/G 13F Company 13D/G 13F	9.2% Reported 13D/G · 31 Mar 2025	$7,453,418 24,844,725 shares	+$7,200,909	31 Mar 2025
David Natan	3/4/5 Director 3/4/5	— mixed-class rows	$331,500 800,000 shares mixed-class rows	—	26 Feb 2025
Spiro George Rombotis	3/4/5 President and CEO, Director 3/4/5	— mixed-class rows	$227,601 184,728 shares mixed-class rows	—	21 Dec 2023
Kenneth M. Ferguson	3/4/5 Director 3/4/5	— mixed-class rows	$149,016 87,390 shares mixed-class rows	—	30 Jun 2023
Karin L. Walker	3/4/5 Director 3/4/5	— mixed-class rows	$134,596 83,040 shares mixed-class rows	—	30 Jun 2023

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

1,626,479

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2025 vs Q1 2025 Across Filers

Q1 2025 holders

Holder diff

Investor	Q1 2025 Shares	Q1 2025 Shares	Share Diff	Share Chg %	Q1 2025 value	Q1 2025 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend